| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/26/2000 | EP0973804A2 Anti-vegf antibodies |
| 01/26/2000 | EP0973803A1 Peptides useful for reducing symptoms of toxic shock syndrome |
| 01/26/2000 | EP0973802A1 Synthetic peptides useful in biological assays for detecting infections caused by group o hiv-1 viruses |
| 01/26/2000 | EP0973801A1 GnRH ANTAGONISTS |
| 01/26/2000 | EP0973799A1 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
| 01/26/2000 | EP0973798A1 Inhibition of major groove dna binding proteins by modified polyamides |
| 01/26/2000 | EP0973797A1 Peptide compositions which induce immune tolerance and methods of use |
| 01/26/2000 | EP0973740A1 Design, synthesis and use of specific polyamide dna-binding ligands |
| 01/26/2000 | EP0973731A1 Hydroxamic acid derivatives |
| 01/26/2000 | EP0973575A1 Gene therapeutic treatment of blood vessel associated disorders |
| 01/26/2000 | EP0973563A1 System, method and composition for dialysis and shock treatment |
| 01/26/2000 | EP0973550A1 Antagonistic anti-avb3 integrin antibodies |
| 01/26/2000 | EP0973549A2 Intravenous immune globulin formulation containing a non-ionic surface active agent with improved pharmacokinetic properties |
| 01/26/2000 | EP0973548A1 Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes |
| 01/26/2000 | EP0973547A1 Improving binding affinity of antigenic peptides for mhc molecules |
| 01/26/2000 | EP0973544A1 Immunotolerant prothrombin complex preparation |
| 01/26/2000 | EP0973543A1 Method for inactivating pathogens, especially viruses, in a biological material |
| 01/26/2000 | EP0973542A1 Biological pesticide |
| 01/26/2000 | EP0973541A1 Therapeutic, prophylactic and diagnostic agent for cancer, useful for characterising cancer cells with individual properties |
| 01/26/2000 | EP0973540A1 Isolation and structural elucidation of the cytostatic linear and cyclo-depsipeptides dolastatin 16, dolastatin 17, and dolastatin 18 |
| 01/26/2000 | EP0973539A2 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 01/26/2000 | EP0973535A1 Protein crystals, their preparation and use |
| 01/26/2000 | EP0973533A1 Methods for inhibiting bacterial cytotoxicity |
| 01/26/2000 | EP0973530A1 Serum-derived factor inducing cell differentiation and medical uses thereof |
| 01/26/2000 | EP0973518A1 Semi-synthetic studies toward didemnin analogues |
| 01/26/2000 | EP0973502A1 Lipophilic binary systems for the administration of lipophilic compounds |
| 01/26/2000 | EP0973499A1 Diffusional implantable delivery system |
| 01/26/2000 | EP0973461A1 Method of treatment of migraine |
| 01/26/2000 | EP0973391A1 Endoderm, cardiac and neural inducing factors |
| 01/26/2000 | EP0871705A4 Human ccn-like growth factor |
| 01/26/2000 | EP0800649A4 Inhibition of glial cell proliferation |
| 01/26/2000 | EP0788510B1 Dipeptide derivatives, process for producing them and medicaments containing these compounds |
| 01/26/2000 | EP0700305B1 Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them |
| 01/26/2000 | EP0587735B1 T cell receptor peptides as therapeutics for immune-related disease |
| 01/26/2000 | EP0470974B1 Lytic peptides, use for growth, infection and cancer |
| 01/26/2000 | CN1242802A Notch protein and their ligands |
| 01/26/2000 | CN1242768A Antithrombotic organic nitrates |
| 01/26/2000 | CN1242707A Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity |
| 01/26/2000 | CN1242703A Chewing gum contg. colloidal bismuth subcitrate |
| 01/26/2000 | CN1242376A Human nervous specific expression gene |
| 01/26/2000 | CN1242237A Dietetic food composition and dietetic method using such composition |
| 01/26/2000 | CN1242236A Application of congeners of MIP of HHV8 for preventing and treating aids |
| 01/26/2000 | CN1048731C Polynucleotide of drug binding protein as coded CSAID |
| 01/25/2000 | US6018102 A recombinant dna molecule encoding a stabilized protein; where the dna is capable of replication but not expression in a prokaryotic cell and is capable of expression in eukaryotic cell; fungicides, viricides, bactericides, antiprotozoa agent |
| 01/25/2000 | US6018042 An oligonucleotide derivative capable of modulating the biosynthesis of human s-adenosylmethionine decarboxylase enzyme; antiproliferative/antitumor/antimetastasis agents |
| 01/25/2000 | US6018037 A recombinant dna coding for a peptide containing leucine instead of the usual 13th amino acid methionine; production of motilin; therapuetic applications |
| 01/25/2000 | US6018032 A monoclonal antibody capable of binding to an epitope and neutralizing interleukin receptor; diagnosis and therapy for chronic bronchial asthma; antiasthmatic agent |
| 01/25/2000 | US6018029 DNA encoding canine interleukin-1 receptor antagonist |
| 01/25/2000 | US6018028 A poylpeptide; diagnosis and therapy for alzheimer's disease, cachexia due to cancer, aqcuired immune deficiency syndrome, sepsis and trauma |
| 01/25/2000 | US6018025 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd528 as a target |
| 01/25/2000 | US6018020 Amino acid derivatives |
| 01/25/2000 | US6017962 Administering to individual a methionine scavenger homocystine |
| 01/25/2000 | US6017943 Intramolecularly crosslinking hemoglobin to form a synthetic blood |
| 01/25/2000 | US6017942 A peritoneal dialysis solution comprising a therapeutically effective amount of l-carnosine |
| 01/25/2000 | US6017928 Retroviral protease inhibiting compounds |
| 01/25/2000 | US6017903 Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors |
| 01/25/2000 | US6017899 Non-reducing saccharide-forming enzyme, its preparation and uses |
| 01/25/2000 | US6017898 Inhibition of tumor growth by antisense oligonucleotides for IL-8 and IL-8 receptor |
| 01/25/2000 | US6017896 Purine nucleoside phosphorylase gene therapy for human malignancy |
| 01/25/2000 | US6017890 Azole peptidomimetics as thrombin receptor antagonists |
| 01/25/2000 | US6017888 Stimulation of hair growth by peptide copper complexes |
| 01/25/2000 | US6017887 Peptide, peptide analog and amino acid analog protease inhibitors |
| 01/25/2000 | US6017886 Use of NDF peptide as growth factor for sensory epithelium |
| 01/25/2000 | US6017885 IGF/IGFBP complex for promoting bone formation and for regulating bone remodeling |
| 01/25/2000 | US6017884 Method for treating acute hepatic failure |
| 01/25/2000 | US6017883 Composition and methods for the inhibition of phagocytes |
| 01/25/2000 | US6017882 Modified vitamin K-dependent polypeptides |
| 01/25/2000 | US6017881 Method of treating conditions associated with intestinal ischemia/reperfusion |
| 01/25/2000 | US6017880 Inhibition of retrovirus infection |
| 01/25/2000 | US6017879 Template associated NPY Y2-receptor agonists |
| 01/25/2000 | US6017878 Nerve growth factor structural analogs and their uses |
| 01/25/2000 | US6017877 Method and composition for treating thrombosis |
| 01/25/2000 | US6017876 Monosuccinylated exclusively a n-terminus |
| 01/25/2000 | US6017763 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/25/2000 | US6017759 Chimeric infectious bursal disease virus cDNA clones, expression products and vaccines based thereon |
| 01/25/2000 | US6017756 A catalytic rna enzyme, or ribozyme; therapy for hepatitis b |
| 01/25/2000 | US6017755 MADR2 tumour suppressor gene |
| 01/25/2000 | US6017744 Human N-acetyl transferase |
| 01/25/2000 | US6017731 Nucleotide sequences encoding a signal sequence, a propeptide leader sequence, a preferred processing site cleaved in situ by a yeast proteolytic enzyme; expressing mammalian proteins and their secretion in a biologically active mature form |
| 01/25/2000 | US6017730 Method of limiting the survival of genetically engineered microorganisms in their environment |
| 01/25/2000 | US6017729 Receptor activator of NF-κB |
| 01/25/2000 | US6017728 ribH |
| 01/25/2000 | US6017717 Human thymosin β15 gene, protein and uses thereof |
| 01/25/2000 | US6017716 Mixing biological sample with an isolated protein and determining binding of antibodies in sample to protein; antibody binding idicates melanoma |
| 01/25/2000 | US6017714 Netrins |
| 01/25/2000 | US6017697 Excitatory amino acid receptor protein and related nucleic acid compounds |
| 01/25/2000 | US6017692 Methods of detecting a malignant cell in a biological sample comprising measuring Mxi gene expression alterations |
| 01/25/2000 | US6017545 Mixed micellar delivery system and method of preparation |
| 01/25/2000 | US6017544 Isolating stress protein-peptide complex from tumor cells previously removed from a mammal and administering the isolated stress protein-peptide complex along with a cytokine to the mammal in order to stimulate an immune response |
| 01/25/2000 | US6017541 Methyl ecgonine phenylphosphonates as analogues of transition states for the hydrolysis of the benzoyl ester of an ecgonine derivative, namely cocaine, and their linking to carrier proteins for use as immunogens |
| 01/25/2000 | US6017540 Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes |
| 01/25/2000 | US6017536 Simian immunodeficiency virus peptides with antifusogenic and antiviral activities |
| 01/25/2000 | US6017533 Assessing the signal transduction ability of pacap type 1 receptor-expressing cells in a mammalian tissue by contacting them with an agonist/antagonist peptide and assaying the affinity |
| 01/25/2000 | US6017531 An extracellular neutral protease and a stabilizer of glyceryl cocoate as a wound healing agent and for debriding necrotic tissue; storage stable enzyme activity at room temperature; burns; cutaneous ulcers; pressure necroses incisional, |
| 01/25/2000 | US6017529 A purified human spermidine/spermine n1-acetyltransferase comprising the amino acid sequence of seq id no:1; diagnostic assays; prevention and treatment of cancer |
| 01/25/2000 | US6017528 Therapeutic treatment of group A streptococcal infections |
| 01/25/2000 | US6017527 Activated dendritic cells and methods for their activation |
| 01/25/2000 | US6017524 Inhibiting the growth p53 deficient tumor cells by administering the p53 gene |
| 01/25/2000 | US6017523 Treating a immunodeficiency, hematopoietic or bone marrow disorder ;stimulants; anticarcinogenic agents; side effect reduction; muteins having several variations, preferably in one to three amino acids |
| 01/25/2000 | US6017514 Contacting a labeled antibody specific to an internal cell component but not with external ones with tissue of a mammal that has received therapy to kill malignant cells; measuring the binding where the internal component is an antigen |